If you’ve battled the sniffles (or worse) this cold and flu season, you may wonder if zinc-rich foods can lend a helping hand ...

Seasonal changes challenge our immune systems with varying temperatures and pathogens. Key nutrients like vitamins C, D, and ...

Vistra is navigating a challenging period as a series of recent developments have impacted its share price, which experienced a 14% decline last week. The announcement of their 2025 earnings ...

Vistra Corp. (VST) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

Vitamin C and zinc are fundamental nutrients which strengthen the immune system, particularly during seasons susceptible to widespread colds and flu. Though these nutrients are present naturally ...

Vistra (NYSE:VST) +4.8% in Tuesday's trading as Bank of America upgrades shares to Buy from Neutral with a $152 price target, following the stock’s recent underperformance resulting from the ...

Deep-pocketed investors have adopted a bullish approach towards Vistra VST, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Daiwa initiated coverage of Vistra (VST) with a Neutral rating and $120 price target Vistra is a “great” artificial intelligence story, but this is already in the share price, the analyst ...

Learn More » Vistra has become one of the favored plays on the theme thanks to its growing capacity in nuclear power. The company started 2024 with 2,400 megawatts (MW) of its 36,702 MW of total ...

Daiwa initiated coverage of Vistra (VST) with a Neutral rating and $120 price target The firm believes Vistra will be a key beneficiary of the tailwinds of U.S. power revival via leveraging its ...

Vistra has a fifty-two week low of $57.50 and a fifty-two week high of $199.84. The stock has a market capitalization of $38.77 billion, a price-to-earnings ratio of 21.26, a price-to-earnings ...